|
|
Post by savzak on Dec 14, 2014 10:19:39 GMT -5
|
|
|
|
Post by savzak on Dec 14, 2014 11:00:21 GMT -5
Dr. Bode is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia, and is currently on the faculty of Emory University, as a Clinical Associate Professor in the Department of Medicine.
He received his medical degree from Emory University School of Medicine and completed an internship and residency in internal medicine at Emory University Affiliated Hospitals and a fellowship in diabetes with Paul C. Davidson, MD.
He has a strong affinity for working with children and young adults with diabetes and is considered one of the leading experts in the world on insulin delivery and glucose sensing. He is very active in clinical research on new diabetes products including pharmacological agents to prevent diabetes and control glucose and new insulins and glucose sensors.
He is a prolific writer with over 200 articles and books in the field of diabetes discussing current and future therapies for people with diabetes. He also sits on the advisory board of many of the leading companies in the field of diabetes care and research including the Juvenile Diabetes Research Foundation, the American Diabetes Association (ADA), and the Georgia diabetes camps.
atlantadiabetes.com/our-physicians/bruce-w-bode-md/ |
|
|
|
Post by jimo on Dec 14, 2014 11:08:06 GMT -5
|
|
|
|
Post by gwb on Dec 14, 2014 12:00:45 GMT -5
Thanks for the post. Some of the slides appear updated from the original date on them , the Dreamboat is shown vs the Medtone. I wonder what data/results have been studied in 2014 using Afrezza with pumps. I guess MDT & SNY know ! 
|
|
|
|
Post by savzak on Mar 9, 2015 14:45:23 GMT -5
Afrezzauser just met with Dr. Bode in Atlanta. Here's his tweet:
afrezzauser afrezzauser · 20m20 minutes ago
Was at Atlanta Diabetes Ctr w/ Dr. Bruce Bode-He used the word "Unbelievable" 8 times to describe my results on #Afrezza @sanofius #diabetes
|
|
|
|
Post by mnholdem on Mar 9, 2015 18:49:34 GMT -5
I read that post by afrezzauser regarding Dr Bode's reaction. Bode has over 250 publications, articles & books and supposedly is an internationally-recognized expert on emerging diabetes treatments. He would be a good one to get behind Afrezza.
I'm impressed how Sam is taking Afrezza to some movers & shakers in the medical community.
|
|
|
|
Post by pktrump on Mar 10, 2015 8:40:32 GMT -5
Dr Bodes reaction is reaffirming. Sams enthusiasm not to mention CGM readings are inspiring.
Hearing Dr Bodes name brings back to mind the various trials be conducted on the Artificial Pancreas and Bionic Pancreas, Closed loop and Open Loop systems, and the variety of Insulin Pumps with incorporated CGMs being developed by MDT, J&J, etc.. at Boston U, Mass Gen, and UCSB with the support of the JDRF. Would like to hear Dr Bodes speak of how he thinks automated insulin delivery & CGM will be incorporated into T1s, particularly children, and how AFZ may alter pump and software design. The Samsun Bionic Pancreas project is the only one utilizing AFZ for meal time control in combo with insulin pump and CGM (dexcom).
Does Sam (Afrezzauser) only utilize AFZ and a CGM? i.e. no insulin pump, no SQ?
|
|
|
|
Post by ezrasfund on Mar 10, 2015 8:52:41 GMT -5
Sam Finta aka Afrezzauser is a Type 1 diabetic, so he also uses basal insulin, as all T1's must.
|
|
|
|
Post by pktrump on Mar 10, 2015 13:00:30 GMT -5
Thanks. I am aware of T1s need for basal insulin. Just thought I had read he was experimenting or testing his glucose control with AFZ only. I am probably mistaken.  |
|
